Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $11.48 USD
Change Today +1.96 / 20.59%
Volume 8.1M
NKTR On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at nektar therapeutics (NKTR)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
Howard Robin 74 RelationshipsChief Executive Officer, President and DirectorChief Executive Officer61

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
Robert Chess 139 RelationshipsChairman of the BoardNektar Therapeutics57
Roy Whitfield 46 RelationshipsMember of the Board of DirectorsIncyte Corporation60
Susan Wang 56 RelationshipsMember of the Board of DirectorsNektar Therapeutics63
Lutz Lingnau 39 RelationshipsMember of the Board of DirectorsNektar Therapeutics71
Christopher Kuebler 35 RelationshipsMember of the Board of DirectorsNektar Therapeutics60
Jeanine Wiener-Kronish M.D. 27 RelationshipsMember of Advisory BoardThe General Hospital Corporation--
Phillip White 27 RelationshipsMember of Advisory BoardNektar Therapeutics--
Allen Sedman M.D., Ph.D. 27 RelationshipsMember of Advisory BoardNektar Therapeutics--
Michael Matthay M.D. 55 RelationshipsMember of Advisory BoardNektar Therapeutics--
Neil MacIntyre M.D. 35 RelationshipsMember of Advisory BoardNektar Therapeutics--
Dean Hess Ph.D. 27 RelationshipsMember of Advisory BoardNektar Therapeutics--
Carl Peck M.D., Dr h.c. (Uppsala) 66 RelationshipsMember of Advisory BoardNDA Partners LLC72
Jedd Shellito M.D. 27 RelationshipsMember of Advisory BoardNektar Therapeutics--
Jay Kolls M.D. 51 RelationshipsMember of Advisory BoardNektar Therapeutics--
Talmadge King M.D. 60 RelationshipsMember of Advisory BoardNektar Therapeutics--
Warren Gold M.D. 27 RelationshipsMember of Advisory BoardNektar Therapeutics--
Rubin Tuder M.D. 55 RelationshipsMember of Advisory BoardNektar Therapeutics--
Paul Blanc M.D. 27 RelationshipsMember of Advisory BoardNektar Therapeutics--
Joseph Krivulka 34 RelationshipsMember of the Board of DirectorsAkrimax Pharmaceuticals, LLC62
Paul Scigalla M.D. 27 RelationshipsMember of Advisory BoardNektar Therapeutics--
Richard Schilsky M.D. 39 RelationshipsMember of Advisory BoardNektar Therapeutics--
Jerome Schentag Pharm D 27 RelationshipsMember of Advisory BoardNektar Therapeutics--
Gene Resnick M.D. 88 RelationshipsMember of Advisory BoardAptiv Solutions, Inc.65
Daniel Von Hoff M.D., F.A.C.P. 584 RelationshipsMember of Advisory BoardAptose Biosciences Inc.66
Dennis Maki M.D. 58 RelationshipsMember of Advisory BoardNanoVibronix Inc.--
Dennis Winger 49 RelationshipsMember of the Board of DirectorsAccuray Incorporated66
R. Greer CPA 78 RelationshipsMember of the Board of DirectorsIzalex, Inc.56
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NKTR:US $11.48 USD +1.96

NKTR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Depomed Inc $23.86 USD +0.60
Emergent Biosolutions Inc $30.74 USD +1.05
Ironwood Pharmaceuticals Inc $13.92 USD +0.26
Sucampo Pharmaceuticals Inc $18.57 USD +0.81
Theravance Inc $16.63 USD +0.38
View Industry Companies
 

Industry Analysis

NKTR

Industry Average

Valuation NKTR Industry Range
Price/Earnings 57.1x
Price/Sales 5.2x
Price/Book 19.5x
Price/Cash Flow 57.8x
TEV/Sales 3.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEKTAR THERAPEUTICS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.